First insights into the safety and effectiveness of additional courses with cladribine tablets under real-world conditions

Kleinschnitz, Christoph; Skuljec, Jelena; Kowarik, Markus C.; Ernst, Michael; Woitschach, Lara; Cepek, Lukas; Rau, Daniela; Kuehnler, Benedicta; Schlemilch-Paschen, Sylke; Schwab, Matthias; Pul, Refik

dc.contributor.author	Woitschach, Lara
dc.contributor.author	Kowarik, Markus
dc.date.accessioned	2026-03-23T06:20:44Z
dc.date.available	2026-03-23T06:20:44Z
dc.date.issued	2025
dc.identifier.issn	2211-0348
dc.identifier.uri	http://hdl.handle.net/10900/177363
dc.language.iso	en	de_DE
dc.publisher	London : Elsevier Sci Ltd	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.msard.2025.106398	de_DE
dc.subject.ddc	610	de_DE
dc.title	First insights into the safety and effectiveness of additional courses with cladribine tablets under real-world conditions	de_DE
dc.type	Article	de_DE
utue.quellen.id	20250630000000_01151
utue.personen.roh	Kleinschnitz, Christoph
utue.personen.roh	Skuljec, Jelena
utue.personen.roh	Kowarik, Markus C.
utue.personen.roh	Ernst, Michael
utue.personen.roh	Woitschach, Lara
utue.personen.roh	Cepek, Lukas
utue.personen.roh	Rau, Daniela
utue.personen.roh	Kuehnler, Benedicta
utue.personen.roh	Schlemilch-Paschen, Sylke
utue.personen.roh	Schwab, Matthias
utue.personen.roh	Pul, Refik
dcterms.isPartOf.ZSTitelID	Multiple Sclerosis and Related Disorders	de_DE
dcterms.isPartOf.ZS-Issue	Article 106398	de_DE
dcterms.isPartOf.ZS-Volume	97	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE